fbpx
Friday, January 22, 2021

Advertising

Home Business News Early results in as COVID vaccine frontrunner by Oxford University and AstraZeneca...

Early results in as COVID vaccine frontrunner by Oxford University and AstraZeneca tested on high risk groups – 7NEWS.com.au

Early results from tests for a coronavirus vaccine being developed by the University of Oxford, in collaboration with AstraZeneca, show it produces a robust immune response in elderly people, the group at highest risk, the Financial Times reports.
Researchers discovered the vaccine triggered protective antibodies and T-cells in older age groups, the newspaper reported on Monday, citing two people familiar with the finding, encouraging scientists as they seek evidence that it will spare those in…

Click here to view the original article.

- Advertisment -
- Advertisment -

Most Popular

Biden weighs “social cost” of carbon in reversing Trump-era climate damage

Newly inaugurated President of the United States Joe Biden hit the ground running Wednesday (Thursday morning, Australia time) in instituting his administration’s climate...

Creative industry talent on the move, in search of hybrid working & creativity

The creative industry should expect talent movement this year, with pursuing new opportunities on the cards for the majority of respondents in Hidden...

Dan Andrews says Margaret Court’s ‘disgraceful’ views are not worthy of an Australia Day honour

Victorian Premier Dan Andrews has criticised the decision to bestow controversial tennis great Margaret Court with an Australia Day honour, saying her “disgraceful...

RSPCA’s Pets of the Week – Piper, Mistletoe & Elf

Sweet Piper is looking for a patient and loving family ready to give her a second chance. Meet our lovable Pets of the Week...

You might also like ...

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of 9F Inc. (JFU) Investors
Graphite Electrodes Market Research Report – Global Forecast to 2024 – Cumulative Impact for COVID-19 Recovery | SpendEdge